Trial intelligence / Profile preview

Preemptive bromelain analgesia for mandibular third molar extraction (split-mouth RCT)

ChiCTR2500107642Phase 4Recruiting

Sponsor
Quanzhou Medical College
Start
Aug 2025
Modality
Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised trial in postoperative pain comparing Bromelain preemptive analgesia with Placebo pre-treatment (2 arms). Primary endpoint: Postoperative pain. Started Aug 2025; status: recruiting.

02

Drugs

bromelain
03

Conditions

postoperative pain

Beyond the preview

Go deeper on ChiCTR2500107642.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500107642.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call